Insider · CIK 0001842133
Elisabeth Leiderman
Files at BLUE (bluebird bio, Inc.), AUTL (Autolus Therapeutics plc). First filing -, latest -.
In brief
Elisabeth Leiderman files SEC Form 4 as director at BLUE (bluebird bio, Inc.), and also at AUTL (Autolus Therapeutics plc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Elisabeth Leiderman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | AUTL Autolus Therapeutics plc | AGrant or award Restricted Share Unitsderivative | +31,667 | $0.00 | $0 | 31,667 | Jul 1, 2026 |
| Jun 29, 2026 | AUTL Autolus Therapeutics plc | AGrant or award Share Option (Right to Buy)derivative | +47,500 | $0.00 | $0 | 47,500 | Jul 1, 2026 |
| May 30, 2025 | BLUE bluebird bio, Inc. | UTender of shares Common Stock | -1,112 | - | - | 1,245 | Jun 3, 2025 |
| Jun 2, 2025 | BLUE bluebird bio, Inc. | DDisposition to issuer Common Stock | -1,245 | - | - | 0 | Jun 3, 2025 |
| Nov 6, 2024 | BLUE bluebird bio, Inc. | AGrant or award Common Stock | +24,900 | $0.00 | $0 | 47,156 | Nov 8, 2024 |
| Nov 6, 2024 | BLUE bluebird bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +49,850 | $0.00 | $0 | 49,850 | Nov 8, 2024 |
Questions about Elisabeth Leiderman
Answered from the filings on this page, as of the latest one.
Is Elisabeth Leiderman buying or selling?
Elisabeth Leiderman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Elisabeth Leiderman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Elisabeth Leiderman has 0.
Where does Elisabeth Leiderman file Form 4?
Elisabeth Leiderman has filed Form 4 at BLUE (bluebird bio, Inc.); AUTL (Autolus Therapeutics plc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.